FDA Clearance Tracker · K212204
Synovasure Alpha Defensin Lateral Flow Test Kit (1 Kit), Synovasure Alpha Defensin Lateral Flow Test Kit (5 Test), Synovasure Alpha Defensin Lateral Flow Test Kit (10 Test), Synovasure Alpha Defensin Flow Test Kit (30 Test), Synovasure Alpha Defensin Control Kit
Last checked: Nov 20, 2026Latest source record: Aug 11, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Aug 11, 2021
Substantially Equivalent
Time to decision
27 days
Received Jul 15, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K212204
- Device name
- Synovasure Alpha Defensin Lateral Flow Test Kit (1 Kit), Synovasure Alpha Defensin Lateral Flow Test Kit (5 Test), Synovasure Alpha Defensin Lateral Flow Test Kit (10 Test), Synovasure Alpha Defensin Flow Test Kit (30 Test), Synovasure Alpha Defensin Control Kit
- Applicant
- Cd Diagnostics, Inc.
- Applicant location
- Claymont, DE
- Received
- Jul 15, 2021
- Decided
- Aug 11, 2021
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3230
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QGN. The earliest in FDA's data is DEN180032, decided May 23, 2019.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K212204
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Cd Diagnostics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
DEN180032 · Decided May 23, 2019 · 328 days after receipt
Device type: Lateral Flow Immunochromatography Assay For Host Infection Biomarkers (QGN) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.